Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Abroad (travel likely)RecruitingPHASE2
Conditions
Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan
Contact: Principal Investigator (Tomoko Okamoto, MD)
Study leads
Tomoko Okamoto, MD
Principal Investigator
National Center of Neurology and Psychiatry